Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer

NCT00519324 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals